PS
Science & Medicine

Polina Stepensky

Share
Who

Polina Stepensky · Science & Medicine

What

Head of bone marrow transplantation and cancer immunotherapy at Hadassah; pioneer of transplants for rare immune disorders in children and co-developer of an Israeli CAR-T therapy for multiple myeloma

When

1967, Vinnytsia, Ukraine (Soviet Union)

Where

Vinnytsia · Haifa · Jerusalem

Biography

Polina Stepensky is recognized among Israeli contributors to Science & Medicine — Head of bone marrow transplantation and cancer immunotherapy at Hadassah; pioneer of transplants for rare immune disorders in children and co-developer of an Israeli CAR-T therapy for multiple myeloma

How & why

Origins and early life

Polina Stepensky was born in 1967 in Vinnytsia, in Soviet Ukraine, the only child of her parents, and began medical school there at the age of nineteen.

Work and career

She has recalled that being an only child was common in Jewish families in the Soviet Union, and that her father told her she had to achieve two hundred percent to be judged at one hundred, “because we are Jewish”. In 1990, halfway through her studies, she left for Israel with her husband Igor, and her parents followed a few months later, among the hundreds of thousands of Jews who came from the former Soviet Union. With limited Hebrew and no English, she first trained as a nurse at the University of Haifa, then won a place at the Hadassah–Hebrew University School of Medicine in Jerusalem, paying her way as a pediatric nurse at Hadassah.

She graduated in 1998, trained in pediatrics and pediatric hemato-oncology at Hadassah, and spent 2008 at the University of Minnesota's blood and marrow transplant program before building a pediatric transplant team in Jerusalem. With the geneticist Orly Elpeleg, her team identified six genetic mutations behind life-threatening immune disorders and was the first in the world to cure children carrying them by transplantation, one such case being reported in the journal Blood in 2015.

After seeing CAR-T cell therapy in New York in 2017, she persuaded Hadassah to develop its own with the Bar-Ilan University immunologist Cyrille Cohen, as head of its department of bone marrow transplantation and cancer immunotherapy. By 2023 more than 90 percent of the 74 multiple myeloma patients treated with this Israeli-made therapy at Hadassah had responded, and the Jerusalem Post named her that year among its fifty most influential Jews.

Sources & external links

Verify and go deeper with these external references.

Source: Hadassah Magazine 2016 and 2023; Jerusalem Post 50 Most Influential Jews 2023

This page is published in seven languages from an English source. The translations are reviewed, but a mistake can still slip through. If you spot one on this profile — a wrong word, a lost date, a sentence that says something the English does not — please tell us.

Contributions & Sources

Head of bone marrow transplantation and cancer immunotherapy at Hadassah; pioneer of transplants for rare immune disorders in children and co-developer of an Israeli CAR-T therapy for multiple myeloma

2023

Source: Hadassah Magazine 2016 and 2023; Jerusalem Post 50 Most Influential Jews 2023